Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Sinovac Vaccine Not Behind Minor Illnesses Got by Trial Volunteers: Team

11 November 2020 22:20 WIB

TEMPO.CO, JakartaCOVID-19 Vaccine Clinical Trial Research Team from the University of Padjadjaran recorded that some 20 volunteers of the Sinovac vaccine trial in Bandung developed a minor illness. Less than five other volunteers also fell ill and are hospitalized.

“So far, it is found that the illnesses are not associated with the vaccine,” said the research team manager, Eddy Fadlyana, on Wednesday, November 11, 2020.

According to Eddy, there must be one or two volunteers who are reported to get sick, such as cold or cough every day. Some of them even experienced recurrent hypertension, typhus, rheumatism, and abdominal pain.

However, like other people, they visit the community health center (Puskesmas) or a doctor. “Unless there is a volunteer who is hospitalized for serious disease, so the person will be monitored for 24 hours,” he explained.

Eddy reiterated that his team immediately reports to the ethics committee and research sponsors including Bio Farma, if there is a trial volunteer who is hospitalized. The team will then carry out studies based on the doctor’s notes, laboratory examinations, and X-rays results.

While the patient is treated for about three to four days, he went on, all data are collected for review. “Based on the expert team’s analysis, it is concluded that their illness has nothing to do with the Sinovac vaccine,” Eddy remarked.

If the cause of the illness could not be determined, the COVID-19 vaccination trial could be temporarily suspended. “In Bandung, the results [of patients’ illness] are not associated with the vaccine, so we continue [the trial],” said Eddy.

Read: Sinovac Vaccine Trial in Brazil Halted; Bio Farma Responds

ANWAR SISWADI 




MER-C Head Spills Challenges Faced as Medical Team Enters Gaza

8 hari lalu

MER-C Head Spills Challenges Faced as Medical Team Enters Gaza

MER-C Chairman Sarbini Abdul Murad revealed the challenges of sending a medical team to Gaza amid Israel's attacks and strict blockade.


Indonesian Volunteers Share Fasting Experience in Gaza Amid Food Crisis

15 hari lalu

Indonesian Volunteers Share Fasting Experience in Gaza Amid Food Crisis

An Indonesian volunteer of the Medical and Humanitarian Institute (MER-C) Fikri Rofiul Haq shared his experience of fasting in Gaza.


Indonesian Mer-C Volunteers in Gaza Fall Ill Amid Water, Medical Crisis

57 hari lalu

Indonesian Mer-C Volunteers in Gaza Fall Ill Amid Water, Medical Crisis

Two Indonesian medical volunteers in Gaza who opted to stay in Gaza have fallen ill and are still recovering.


Today's Top 3 News: Indonesia Still Provides Free COVID-19 Vaccines for Vulnerable Groups, Jakarta Produces 130 Tons of New Year's Eve Waste

2 Januari 2024

Today's Top 3 News: Indonesia Still Provides Free COVID-19 Vaccines for Vulnerable Groups, Jakarta Produces 130 Tons of New Year's Eve Waste

Here is the list of the top 3 news on Tempo English today.


Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

2 Januari 2024

Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

Indonesia's Health Ministry has announced that COVID-19 vaccines would remain free of charge for two vulnerable groups starting from January 1, 2024.


Indonesian Volunteers in Gaza Confirmed Safe by MER-C

21 November 2023

Indonesian Volunteers in Gaza Confirmed Safe by MER-C

MER-C president confirmed that three Indonesian citizens volunteering at the Indonesian Hospital in Gaza are safe and sound after the Israeli attack.


Bio Farma, MSD to Launch NusaGard Cervix Cancer Vaccines in Indonesia

2 Agustus 2023

Bio Farma, MSD to Launch NusaGard Cervix Cancer Vaccines in Indonesia

Bio Farma collaborates with MSD to launch NusaGard vaccines, the domestically produced human papillomavirus (HPV) vaccine.


Bio Farma 'Post-Covid' Earnings Slump 50 Percent in 2022

21 Juni 2023

Bio Farma 'Post-Covid' Earnings Slump 50 Percent in 2022

The consolidated earnings logged by Bio Farma nosedived to Rp21.54 trillion in 2022, which is a 50.4 percent drop.


Indonesian Health Ministry Provides 4 Million COVID-19 Vaccine Doses for Free

12 Juni 2023

Indonesian Health Ministry Provides 4 Million COVID-19 Vaccine Doses for Free

The Health Ministry distributing COVID-19 vaccine doses free of charge to the public.


Indonesia's Bio Farma Sends 1.5 Million Pentavalent Vaccines to Nigeria

30 Mei 2023

Indonesia's Bio Farma Sends 1.5 Million Pentavalent Vaccines to Nigeria

Bio Farma on Tuesday sent 1.5 million pentavalent vaccine doses under the Pentabio trade brand to Nigeria.